DENTSPLY SIRONA (XRAY) – Analysts’ Weekly Ratings Updates

Several brokerages have updated their recommendations and price targets on shares of DENTSPLY SIRONA (NASDAQ: XRAY) in the last few weeks:

  • 11/16/2026 – DENTSPLY SIRONA had its price target lowered by UBS Group from $17.00 to $13.00. They now have a “buy” rating on the stock.
  • 11/9/2026 – DENTSPLY SIRONA was downgraded by Zacks Research from “hold” to “strong sell”.
  • 11/6/2026 – DENTSPLY SIRONA had its “buy” rating reaffirmed by Bank of America.
  • 11/6/2026 – DENTSPLY SIRONA had its price target lowered by JPMorgan Chase & Co. from $12.00 to $10.00. They now have a “neutral” rating on the stock.
  • 10/30/2026 – DENTSPLY SIRONA had its “sell (e+)” rating reaffirmed by Weiss Ratings.
  • 10/26/2026 – DENTSPLY SIRONA had its price target lowered by Barrington Research from $15.00 to $13.00. They now have an “outperform” rating on the stock.
  • 10/22/2026 – DENTSPLY SIRONA had its price target lowered by Mizuho from $14.00 to $12.00. They now have a “neutral” rating on the stock.
  • 10/14/2026 – DENTSPLY SIRONA had its price target lowered by Leerink Partners from $14.00 to $10.00. They now have a “market perform” rating on the stock.
  • 10/9/2026 – DENTSPLY SIRONA had its price target lowered by Piper Sandler from $14.00 to $12.00. They now have a “neutral” rating on the stock.

DENTSPLY SIRONA Stock Performance

NASDAQ:XRAY opened at $8.49 on Friday. DENTSPLY SIRONA Inc. has a 1 year low of $8.14 and a 1 year high of $14.76. The firm’s fifty day simple moving average is $9.25 and its 200 day simple moving average is $11.12. The company has a current ratio of 1.63, a quick ratio of 1.04 and a debt-to-equity ratio of 1.47. The firm has a market capitalization of $1.68 billion, a PE ratio of -13.69, a PEG ratio of 1.25 and a beta of 0.87.

DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) last announced its earnings results on Thursday, November 5th. The medical instruments supplier reported $0.29 EPS for the quarter, missing the consensus estimate of $0.31 by ($0.02). The firm had revenue of $836.00 million during the quarter, compared to the consensus estimate of $861.68 million. DENTSPLY SIRONA had a positive return on equity of 20.21% and a negative net margin of 3.38%. The business’s revenue was down 7.5% compared to the same quarter last year. During the same quarter last year, the business earned $0.37 EPS. DENTSPLY SIRONA has set its FY 2026 guidance at 1.200-1.300 EPS. On average, sell-side analysts anticipate that DENTSPLY SIRONA Inc. will post 1.21 EPS for the current year.

DENTSPLY SIRONA Inc. develops, manufactures and markets products and technologies for dental professionals. Its portfolio includes dental equipment and imaging systems, digital dentistry and CAD/CAM solutions, dental implants, endodontic and restorative products, and supplies used in preventive care. The company serves dental practices, laboratories and other customers around the world. Its products support a range of clinical activities, including diagnosis, treatment planning, restorative dentistry and oral hygiene.

Read More

Receive News & Ratings for DENTSPLY SIRONA Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc and related companies with MarketBeat.com's FREE daily email newsletter.